DK1129212T3 - Screeningsproces for antibakterielle midler - Google Patents

Screeningsproces for antibakterielle midler

Info

Publication number
DK1129212T3
DK1129212T3 DK99954191T DK99954191T DK1129212T3 DK 1129212 T3 DK1129212 T3 DK 1129212T3 DK 99954191 T DK99954191 T DK 99954191T DK 99954191 T DK99954191 T DK 99954191T DK 1129212 T3 DK1129212 T3 DK 1129212T3
Authority
DK
Denmark
Prior art keywords
antibacterial agents
subpopulation
screening process
identified
bacteria
Prior art date
Application number
DK99954191T
Other languages
English (en)
Inventor
Anthony Robert Milnes Coates
Yanmin Hu
Original Assignee
Helperby Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824553.3A external-priority patent/GB9824553D0/en
Priority claimed from GBGB9909962.4A external-priority patent/GB9909962D0/en
Application filed by Helperby Therapeutics Ltd filed Critical Helperby Therapeutics Ltd
Application granted granted Critical
Publication of DK1129212T3 publication Critical patent/DK1129212T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
DK99954191T 1998-11-09 1999-11-09 Screeningsproces for antibakterielle midler DK1129212T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10765598P 1998-11-09 1998-11-09
GBGB9824553.3A GB9824553D0 (en) 1998-11-09 1998-11-09 Improvements in or relating to screening antibacterial agents
GBGB9909962.4A GB9909962D0 (en) 1999-04-29 1999-04-29 Improvemments in or relating to screening antibacterial agents
EP99954191A EP1129212B1 (en) 1998-11-09 1999-11-09 Screening process for antibacterial agents

Publications (1)

Publication Number Publication Date
DK1129212T3 true DK1129212T3 (da) 2004-11-22

Family

ID=27269546

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99954191T DK1129212T3 (da) 1998-11-09 1999-11-09 Screeningsproces for antibakterielle midler

Country Status (10)

Country Link
US (3) US20020031819A1 (da)
EP (1) EP1129212B1 (da)
JP (1) JP3737365B2 (da)
AT (1) ATE272717T1 (da)
AU (1) AU1061100A (da)
DE (1) DE69919196T2 (da)
DK (1) DK1129212T3 (da)
ES (1) ES2229780T3 (da)
PT (1) PT1129212E (da)
WO (1) WO2000028074A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982153B1 (en) * 1998-12-03 2006-01-03 Targanta Therapeutics, Inc. DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides
GB0522715D0 (en) 2005-11-08 2005-12-14 Helperby Therapeutics Ltd New use
US20080220465A1 (en) * 2007-03-05 2008-09-11 Pocared Diagnostics, Inc. Antibiotic Sensitivity Testing Method
ES2703253T3 (es) 2010-03-30 2019-03-07 Helperby Therapeutics Ltd Nueva combinación y uso
WO2011160048A2 (en) * 2010-06-17 2011-12-22 The Johns Hopkins University Methods of identifying therapeutic agents for treating persister and bacterial infection
GB201013207D0 (en) 2010-08-05 2010-09-22 Helperby Therapeutics Ltd Novel combination
WO2012017215A1 (en) 2010-08-05 2012-02-09 Helperby Therapeutics Limited Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine
GB201015079D0 (en) 2010-09-10 2010-10-27 Helperby Therapeutics Ltd Novel use
GB201305277D0 (en) 2013-03-22 2013-05-01 Helperby Therapeutics Ltd Novel combination and use
GB201307989D0 (en) 2013-05-02 2013-06-12 Helperby Therapeutics Ltd Novel combinations and use
JP6479037B2 (ja) 2013-12-06 2019-03-06 バクテリオスキャン エルティーディー 試料チャンバを有する光学測定キュベット
GB201401617D0 (en) 2014-01-30 2014-03-19 Helperby Therapeutics Ltd Novel combination and use
US20160161404A1 (en) 2014-12-05 2016-06-09 Bacterioscan Ltd System Using Laser-Scatter Measurement Instrument For Organism Identification And Related Network
CN107530397A (zh) 2014-12-18 2018-01-02 赫尔普百治疗有限公司 新型组合和用途
HK1250679A1 (zh) 2015-04-11 2019-01-11 Helperby Therapeutics Limited 口腔用组合物
GB201518969D0 (en) 2015-10-27 2015-12-09 Helperby Therapeutics Ltd Triple combination
GB201521771D0 (en) 2015-12-10 2016-01-27 Helperby Therapeutics Ltd Formulation
GB201610869D0 (en) 2016-06-22 2016-08-03 Helperby Therapeutics Ltd Combination
GB201612093D0 (en) 2016-07-12 2016-08-24 Helperby Therapeutics Ltd Combination
GB201616014D0 (en) 2016-09-20 2016-11-02 Helperby Therapeutics Ltd Combination
GB201616909D0 (en) 2016-10-05 2016-11-16 Helperby Therapeutics Ltd Combination
GB201703898D0 (en) 2017-03-10 2017-04-26 Helperby Therapeautics Ltd Method
GB201704620D0 (en) 2017-03-23 2017-05-10 Helperby Therapeautics Ltd Combinations
GB201709193D0 (en) 2017-06-09 2017-07-26 Helperby Therapeutics Ltd Combination
GB201807046D0 (en) 2018-04-30 2018-06-13 Helperby Therapeutics Ltd Combination
GB2589286A (en) * 2019-07-22 2021-06-02 Helperby Therapeutics Ltd Method
GB201913068D0 (en) 2019-09-10 2019-10-23 Helperby Therapeutics Ltd Combination
GB201914847D0 (en) 2019-10-14 2019-11-27 Helperby Therapeutics Ltd Combination
GB202213750D0 (en) 2022-09-20 2022-11-02 Helperby Therapeutics Ltd Antimicrobial
GB202213753D0 (en) 2022-09-20 2022-11-02 Helperby Therapeutics Ltd Antimicrobial combinations
GB202314387D0 (en) 2023-09-20 2023-11-01 Helperby Therapeutics Ltd Antimicrobial combinations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697648A (en) * 1968-05-24 1972-10-10 Meiji Seika Ltd Kk Antibiotic sf-767-a and sf767-l substances,and process for producing same culturing a certain streptomyces microsporeus
US3963576A (en) 1975-02-21 1976-06-15 General Environmental Science Corporation Method for rendering bacteria dormant and the product produced thereby
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
US5670350A (en) * 1990-08-20 1997-09-23 Novartis Finance Corporation Genomic DNA encoding a pseudomonas global transcriptional activation element and its use in activating gene expression
US5684144A (en) * 1993-07-28 1997-11-04 University Of North Texas Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof
US5712095A (en) * 1994-06-16 1998-01-27 Becton Dickinson And Company Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probes specific for ribosomal RNA precursors
US5733774A (en) * 1995-02-02 1998-03-31 Ecoscience Corporation Method and composition for producing stable bacteria and bacterial formulations
US5700925A (en) * 1996-03-27 1997-12-23 The Johns Hopkins University DNA encoding stationary phase, stress response sigma factor from Mycobacterium tuberculosis
US6890526B2 (en) * 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
US5963576A (en) * 1997-08-04 1999-10-05 Motorola, Inc. Annular waveguide vertical cavity surface emitting laser and method of fabrication

Also Published As

Publication number Publication date
ES2229780T3 (es) 2005-04-16
DE69919196T2 (de) 2005-08-04
US20050019892A1 (en) 2005-01-27
JP3737365B2 (ja) 2006-01-18
JP2002529103A (ja) 2002-09-10
US7892782B2 (en) 2011-02-22
WO2000028074A1 (en) 2000-05-18
EP1129212A1 (en) 2001-09-05
ATE272717T1 (de) 2004-08-15
EP1129212B1 (en) 2004-08-04
US20020031819A1 (en) 2002-03-14
US20090104651A1 (en) 2009-04-23
PT1129212E (pt) 2004-11-30
DE69919196D1 (de) 2004-09-09
AU1061100A (en) 2000-05-29

Similar Documents

Publication Publication Date Title
DK1129212T3 (da) Screeningsproces for antibakterielle midler
PT845991E (pt) Utilizacao de difosfonatos substituidos com fenol como agentes anti-neoplasicos
ATE279942T1 (de) Mehrwertige impstoffzusammensetzung mit gemischten trägern
ES2146782T3 (es) 6-aril-pirido(2,3-d)pirimidinas y naftiridinas para la inhibicion de la proliferacion celular inducida por la proteina tirosina quinasa.
YU234790A (sh) Posotupak za dobijanje glikopeptidnih derivata i glikopeptidni derivati
LV12516A (en) Inhibitors of factor xawith a neutral p1 specifity group
DE69918799D1 (de) Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren
EP0885958A4 (en) METHOD FOR TREATING BIOPOLYMERS, MICROORGANISMS OR OTHER MATERIALS USING MORE THAN ONE TYPE OF MAGNETIC PARTICLES.
EA199700087A1 (ru) Способ ингибирования катепсина к
DE60041770D1 (de) Bifidobacteria zum vorbeugen von diarrhöe infolge pathogener bakterien
ATE256677T1 (de) Inhibitoren der bakteriellen nad synthetase
TR200003384T2 (tr) Arginin türevleri kullanılarak oksazolidinon antibakteriyel maddelerin etkisinin arttırılması
MX9700257A (es) Nuevas estreptograminas y procedimiento de preparacion de estreptograminas por mutasintesis.
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
DE69722771D1 (de) Verfahren zum nachweis der enzymaktivität von mikroorganismen
ATE425179T1 (de) Reinigung von glykopeptiden
DE59201253D1 (de) Verfahren zum, insbesondere beschleunigten, aeroben mikrobiologischen Abbau von biologischen Substanzen.
EP0992549A4 (en) ANTI-DECAY PREVENTING AGENT, METHOD FOR TREATMENT PREVENTING AND OBJECT OBTAINED BY THIS TREATMENT
ATE328898T1 (de) Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
ATE225859T1 (de) Nachweis von antibiotikumresistenzen in mikroorganismen
PT931161E (pt) Processo para a bio-transformacao de compostos de colchicinoide nos correspondentes derivados de 3-glicosilo
ATE333903T1 (de) Verfahren zum auffinden von verbindungen zur vorbeugung von infektion oder pathogenizität
FI963864A0 (fi) Parannettu menetelmä 6,9-bis((2-aminoetyyli)amino)bentso(g)-isokinoliini-5,10-dionin ja sen dimaleaattisuolan syntetisoimiseksi
ATE244706T1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung